Baxter International Inc.

BAX ·Healthcare, Medical Devices, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Operating Activities
Net Income $-957.0M $-649.0M $2.66B $-2.43B $1.28B $1.10B $1.00B $1.55B
Depreciation & Amortization $981.0M $997.0M $984.0M $1.07B $867.0M $823.0M $789.0M $771.0M
Depreciation $383.0M $372.0M $394.0M $393.0M $569.0M $601.0M $606.0M $602.0M
Amortization $598.0M $625.0M $590.0M $679.0M $298.0M $222.0M $183.0M $169.0M
Stock-Based Compensation $117.0M $114.0M $115.0M $140.0M $146.0M $130.0M $122.0M $115.0M
Net Cash from Operating Activities $845.0M $1.02B $1.73B $1.21B $2.22B $1.87B $2.10B $2.02B
Investing Activities
Capital Expenditures $513.0M $446.0M $432.0M $377.0M $691.0M $709.0M $696.0M $659.0M
Business Acquisitions $9.0M $14.0M $4.0M $258.0M $10.50B $494.0M $418.0M $268.0M
Net Cash from Investing Activities $2.84B $-626.0M $3.21B $-931.0M $-11.20B $-1.18B $-1.10B $-916.0M
Financing Activities
Dividends Paid $348.0M $590.0M $586.0M $573.0M $530.0M $473.0M $423.0M $376.0M
Stock Repurchases — $0 $0 $32.0M $600.0M $500.0M $1.27B $2.45B
Net Cash from Financing Activities $-4.22B $-1.08B $-3.49B $-1.44B $8.25B $-345.0M $498.0M $-2.60B
Net Change in Cash $-446.0M $-784.0M $1.48B $-1.23B $-780.0M $401.0M $1.50B $-1.56B
Free Cash Flow $332.0M $573.0M $1.29B $834.0M $1.53B $1.16B $1.41B $1.36B
← Newer Page 1 of 3 Older →